Gynecomastia risk factors: Difference between revisions

	Gynecomastia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Gynecomastia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Gynecomastia risk factors On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Gynecomastia risk factors All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Gynecomastia risk factors
CDC on Gynecomastia risk factors
Gynecomastia risk factors in the news
Blogs on Gynecomastia risk factors
Directions to Hospitals Treating Gynecomastia
Risk calculators and risk factors for Gynecomastia risk factors

Revision as of 16:28, 18 May 2017

Please help WikiDoc by adding content here. It's easy! Click here to learn about

editing.

The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial.

↑ Braunstein GD (1993). "Gynecomastia". N Engl J Med. 328 (7): 490–5. doi:10.1056/NEJM199302183280708. PMID 8421478.

@@ Line 8: / Line 8: @@
 ==Risk Factors==
+===Risk factors===
+: The most potent risk factor in the development of gynecomastia is idiopathic often multifactorial.
+====Common Risk Factors====
+* Idiopathic
+* Drugs (12765)
+** Spironolactone
+** Cimetidine
+** Recombinant Human Growth Hormone
+** Estrogens
+** Human Chorionic gonadotropin
+** Anti-androgens
+** Gonadotropin Releasing hormone (GNRH) agonists
+** 5-alpha reductase inhibitors
+** Ketoconazole
+** steroids
+** INH
+** [[Digoxin]]<ref name="pmid8421478">{{cite journal| author=Braunstein GD| title=Gynecomastia. | journal=N Engl J Med | year= 1993 | volume= 328 | issue= 7 | pages= 490-5 | pmid=8421478 | doi=10.1056/NEJM199302183280708 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8421478  }} </ref>
+* Cirrhosis
+* Starvation and Refeeding
+* Male hypogonadism
+* Testicular neoplasms
+* Hyperthyroidism
+* Chronic Kidney disease
+* Tumors
+====Less Common Risk Factors====
+* Feminizing adrenal tumors
+* Ectopic hCG
+* Disorders of sex development
+* Familial prepubertal gynecomastia
 ==References==